Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-02-24

Clinical Trial Update: Effect of TNF-Inhibition Combined With Conventional DMARDs on Cervical Pannus in Patients With RA and Cervical Spine Involvement

View source ↗

Summary

A clinical trial update evaluating whether adding a TNF-inhibitor to conventional DMARD therapy affects cervical pannus in rheumatoid arthritis patients with ce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TNF inhibitor (tumor necrosis factor inhibitor)

Snippet

Sponsor: University of Zurich | Conditions: Rheumatoid Arthritis | Status: UNKNOWN